Paris, France, December 10, 2004 – Aureus Pharma and Infocom Corporation today announced an agreement which establishes Infocom as the exclusive distributor of Aureus Pharma products in Japan.

Infocom under the terms of the agreement will distribute Aureus Pharma’s AurSCOPE databases, AurSCOPE GPCR, ADME/Drug-Drug Interactions and Ion Channel as well as AurQUEST, a web-based software for interrogating the databases.

“We are very excited to have an opportunity to extend our product line with this new business relationship, said K. Ohgaki, General Manager of Infocom's Bioscience department. “We believe Aureus Pharma’s products will allow us to further penetrate into the Japanese pharmaceutical industry with cutting-edge data content research solutions indispensable to the drug discovery process."

“This agreement with Infocom presents Aureus Pharma with an important opportunity to focus on the Japanese market” said Dr. André Michel CEO of Aureus Pharma. “We are very pleased to be working with Infocom as they have had a strong record in providing support to the bioscience market in Japan.”

About Infocom Corporation

Infocom Corporation headquartered in Tokyo was founded in 1983. Infocom is a comprehensive service IT company carrying out a wide range of business centered on the areas of medical services. In the field of biosciences, they have a strong emphasis on providing support for discovery support and drug information. They offer a variety of solutions including solutions for drug discovery, ADMET, data mining, statistical analysis, proteome analysis and bioinformatics. For more information, see www.infocom.co.jp or contact info-bioscience@infocom.co.jp

Contact:
Mary E. Donlan, Ph.D
Director of Marketing
+33 1 40 18 57 57
mary.donlan@aureus-pharma.com